<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="it">
		<id>https://www.wikifarmaco.org/index.php?action=history&amp;feed=atom&amp;title=Spirofur</id>
		<title>Spirofur - Cronologia</title>
		<link rel="self" type="application/atom+xml" href="https://www.wikifarmaco.org/index.php?action=history&amp;feed=atom&amp;title=Spirofur"/>
		<link rel="alternate" type="text/html" href="https://www.wikifarmaco.org/index.php?title=Spirofur&amp;action=history"/>
		<updated>2026-06-27T11:03:20Z</updated>
		<subtitle>Cronologia della pagina su questo sito</subtitle>
		<generator>MediaWiki 1.30.2</generator>

	<entry>
		<id>https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=54763&amp;oldid=prev</id>
		<title>Hadihajar il 23:15, 6 set 2014</title>
		<link rel="alternate" type="text/html" href="https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=54763&amp;oldid=prev"/>
				<updated>2014-09-06T23:15:39Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;it&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Versione meno recente&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Versione delle 23:15, 6 set 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Riga 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Riga 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Avvertenze bugiardino}}{{#seo:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Avvertenze bugiardino}}{{#seo:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|title= Spirofur &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;(Spironolattone/Furosemide)&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|title= Spirofur &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;- Indicazioni, Posologia, Effetti collaterali, Interazioni&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|titlemode=&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|titlemode=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|keywords= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|keywords= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Indicazioni: Stati edematosi (scompenso cardiaco congestizio, cirrosi epatica in fase ascitica, sindrome nefrosica) ed ipertensione arteriosa da iperaldosteronismo primario e secondario.Ipertensione arteriosa essenziale, laddove altre terapie non sono risultate sufficientemente efficaci o tollerate.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:52749:newid:54763 --&gt;
&lt;/table&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	<entry>
		<id>https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=52749&amp;oldid=prev</id>
		<title>Hadihajar: Sostituzione testo - '&lt;div id=&quot;global-article&quot;&gt;' con ''</title>
		<link rel="alternate" type="text/html" href="https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=52749&amp;oldid=prev"/>
				<updated>2014-08-29T01:56:39Z</updated>
		
		<summary type="html">&lt;p&gt;Sostituzione testo - &amp;#039;&amp;lt;div id=&amp;quot;global-article&amp;quot;&amp;gt;&amp;#039; con &amp;#039;&amp;#039;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;it&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Versione meno recente&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Versione delle 01:56, 29 ago 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l5&quot; &gt;Riga 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Riga 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= Indicazioni: Stati edematosi (scompenso cardiaco congestizio, cirrosi epatica in fase ascitica, sindrome nefrosica) ed ipertensione arteriosa da iperaldosteronismo primario e secondario.Ipertensione arteriosa essenziale, laddove altre terapie non sono risultate sufficientemente efficaci o tollerate.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= Indicazioni: Stati edematosi (scompenso cardiaco congestizio, cirrosi epatica in fase ascitica, sindrome nefrosica) ed ipertensione arteriosa da iperaldosteronismo primario e secondario.Ipertensione arteriosa essenziale, laddove altre terapie non sono risultate sufficientemente efficaci o tollerate.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;&amp;lt;div id=&amp;quot;global-article&amp;quot;&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==1 DENOMINAZIONE DEL MEDICINALE==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==1 DENOMINAZIONE DEL MEDICINALE==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;SPIROFUR 50 mg + 20 mg capsule rigide&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;SPIROFUR 50 mg + 20 mg capsule rigide&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	<entry>
		<id>https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=51876&amp;oldid=prev</id>
		<title>Hadihajar: Sostituzione testo - '|titlemode= append' con '|titlemode='</title>
		<link rel="alternate" type="text/html" href="https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=51876&amp;oldid=prev"/>
				<updated>2014-08-26T20:32:26Z</updated>
		
		<summary type="html">&lt;p&gt;Sostituzione testo - &amp;#039;|titlemode= append&amp;#039; con &amp;#039;|titlemode=&amp;#039;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;it&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Versione meno recente&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Versione delle 20:32, 26 ago 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Riga 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Riga 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Avvertenze bugiardino}}{{#seo:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Avvertenze bugiardino}}{{#seo:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|title= Spirofur (Spironolattone/Furosemide)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|title= Spirofur (Spironolattone/Furosemide)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|titlemode= &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;append&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|titlemode=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|keywords= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|keywords= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= Indicazioni: Stati edematosi (scompenso cardiaco congestizio, cirrosi epatica in fase ascitica, sindrome nefrosica) ed ipertensione arteriosa da iperaldosteronismo primario e secondario.Ipertensione arteriosa essenziale, laddove altre terapie non sono risultate sufficientemente efficaci o tollerate.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= Indicazioni: Stati edematosi (scompenso cardiaco congestizio, cirrosi epatica in fase ascitica, sindrome nefrosica) ed ipertensione arteriosa da iperaldosteronismo primario e secondario.Ipertensione arteriosa essenziale, laddove altre terapie non sono risultate sufficientemente efficaci o tollerate.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	<entry>
		<id>https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=44415&amp;oldid=prev</id>
		<title>Hadihajar: Sostituzione testo - '{{Avvertenze bugiardino}}
{{#seo:' con '{{Avvertenze bugiardino}}{{#seo:'</title>
		<link rel="alternate" type="text/html" href="https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=44415&amp;oldid=prev"/>
				<updated>2014-03-21T03:59:21Z</updated>
		
		<summary type="html">&lt;p&gt;Sostituzione testo - &amp;#039;{{Avvertenze bugiardino}} {{#seo:&amp;#039; con &amp;#039;{{Avvertenze bugiardino}}{{#seo:&amp;#039;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;it&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Versione meno recente&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Versione delle 03:59, 21 mar 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Riga 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Riga 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Avvertenze bugiardino}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Avvertenze bugiardino}}{{#seo:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#seo:&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|title= Spirofur (Spironolattone/Furosemide)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|title= Spirofur (Spironolattone/Furosemide)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|titlemode= append&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|titlemode= append&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:43167:newid:44415 --&gt;
&lt;/table&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	<entry>
		<id>https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=43167&amp;oldid=prev</id>
		<title>Hadihajar: Creata pagina con '{{Avvertenze bugiardino}} {{#seo: |title= Spirofur (Spironolattone/Furosemide) |titlemode= append |keywords=  |description= Indicazioni: Stati edematosi (scompenso cardiaco co...'</title>
		<link rel="alternate" type="text/html" href="https://www.wikifarmaco.org/index.php?title=Spirofur&amp;diff=43167&amp;oldid=prev"/>
				<updated>2014-03-12T22:27:50Z</updated>
		
		<summary type="html">&lt;p&gt;Creata pagina con &amp;#039;{{Avvertenze bugiardino}} {{#seo: |title= Spirofur (Spironolattone/Furosemide) |titlemode= append |keywords=  |description= Indicazioni: Stati edematosi (scompenso cardiaco co...&amp;#039;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nuova pagina&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Avvertenze bugiardino}}&lt;br /&gt;
{{#seo:&lt;br /&gt;
|title= Spirofur (Spironolattone/Furosemide)&lt;br /&gt;
|titlemode= append&lt;br /&gt;
|keywords= &lt;br /&gt;
|description= Indicazioni: Stati edematosi (scompenso cardiaco congestizio, cirrosi epatica in fase ascitica, sindrome nefrosica) ed ipertensione arteriosa da iperaldosteronismo primario e secondario.Ipertensione arteriosa essenziale, laddove altre terapie non sono risultate sufficientemente efficaci o tollerate.&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;div id=&amp;quot;global-article&amp;quot;&amp;gt;&lt;br /&gt;
==1 DENOMINAZIONE DEL MEDICINALE==&lt;br /&gt;
SPIROFUR 50 mg + 20 mg capsule rigide&lt;br /&gt;
&lt;br /&gt;
==2 COMPOSIZIONE==&lt;br /&gt;
Una capsula contiene:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;[[:categoria:principi attivi|Principi attivi]]&amp;lt;/u&amp;gt;: [[spironolattone]] 50 mg, [[furosemide]] 20 mg&lt;br /&gt;
&lt;br /&gt;
Per l’elenco completo degli eccipienti, vedere il foglio illustrativo&lt;br /&gt;
&lt;br /&gt;
==3 FORMA FARMACEUTICA==&lt;br /&gt;
Capsule rigide.&lt;br /&gt;
&lt;br /&gt;
==4.1 INDICAZIONI==&lt;br /&gt;
Stati [[edema]]tosi (scompenso cardiaco congestizio, cirrosi epatica in fase ascitica, sindrome nefrosica) ed [[ipertensione]] arteriosa da iperaldosteronismo primario e secondario.[[Ipertensione]] arteriosa essenziale, laddove altre terapie non sono risultate sufficientemente efficaci o tollerate.&lt;br /&gt;
&lt;br /&gt;
==4.2 POSOLOGIA==&lt;br /&gt;
1-2 capsule o più al giorno secondo prescrizione medica. Se necessario tale posologia può essere aumentata fino a 8 capsule al giorno.&lt;br /&gt;
&lt;br /&gt;
==4.3 CONTROINDICAZIONI==&lt;br /&gt;
[[Gravidanza]] accertata o presunta e allattamento, insufficienza renale acuta, anuria, iperazotemia ed oliguria in presenza di grave compromissione renale, ipersensibilità individuale accertata ai singoli componenti ed ai sulfamidici. È consigliabile iniziare il trattamento della cirrosi epatica in ambiente ospedaliero.&lt;br /&gt;
&lt;br /&gt;
==4.4 AVVERTENZE E PRECAUZIONI==&lt;br /&gt;
Il trattamento dell’[[edema]] dell’[[ipertensione]] con [[diuretici]] dovrebbe essere preceduto da una verifica dell’idoneità del preparato in rapporto alla sensibilità del soggetto.&lt;br /&gt;
&lt;br /&gt;
Onde evitare il rischio di iperpotassiemia, è consigliabile non associare Spirofur a supplementazione dietetica o farmacologica di potassio. Come per tutti i [[diuretici]] e specialmente durante il trattamento protratto, è necessario effettuare controlli periodici degli elettroliti plasmatici, della funzionalità renale, della riserva alcalina, della glicemia o dell’uricemia. Quando la sodiemia raggiunge un valore inferiore a 130 mEq/l, o la potassiemia un valore superiore a 5 mEq/l il trattamento deve essere interrotto.&lt;br /&gt;
&lt;br /&gt;
Per chi svolge attività sportiva: l’uso del farmaco senza necessità terapeutica costituisce doping e può determinare comunque positività ai test anti-doping.&lt;br /&gt;
&lt;br /&gt;
''Tenere fuori dalla portata e dalla vista dei bambini.''&lt;br /&gt;
&lt;br /&gt;
Il medicinale non è controindicato per i soggetti affetti da&amp;amp;nbsp;malattia celiaca.&lt;br /&gt;
&lt;br /&gt;
==4.5 INTERAZIONI==&lt;br /&gt;
Spirofur può potenziare l’effetto degli [[Antiipertensivi|antipertensivi]] e richiederne quindi una diminuzione del dosaggio. Incrementa la tossicità dei salicilati e dei sali di [[litio]], la nefrotossicità della cefaloridina, aumenta l’effetto della tubocurarina e diminuisce quello delle amine pressorie.&lt;br /&gt;
&lt;br /&gt;
Somministrato contemporaneamente ad [[Ipoglicemizzanti|antidiabetici]], [[corticosteroidi]], clofibrato e digitale, richiede un monitoraggio più frequente degli elettroliti plasmatici, della glicemia e della calcemia onde dosare in modo più appropriato questi farmaci. Può causare [[iperuricemia]] e rendere manifesto un [[diabete]] latente.&lt;br /&gt;
&lt;br /&gt;
==4.6 GRAVIDANZA E ALLATTAMENTO==&lt;br /&gt;
Nella donne in [[gravidanza]] presunta o accertata, l’impiego dello Spirofur richiede che i potenziali effetti terapeutici siano valutati in rapporto a possibili rischi per la madre e il feto.&lt;br /&gt;
&lt;br /&gt;
Ritrovandosi entrambi i principi attivi dell’associazione nel latte materno, è opportuno provvedere all’alimentazione artificiale del neonato.&lt;br /&gt;
&lt;br /&gt;
== 4.7 EFFETTI SUL GUIDARE/USARE MACCHINARI ==&lt;br /&gt;
Non sono noti al riguardo effetti dello Spirofur, nelle normali condizioni di uso terapeutico.&lt;br /&gt;
&lt;br /&gt;
==4.8 EFFETTI INDESIDERATI==&lt;br /&gt;
Gli effetti collaterali con l’uso di [[spironolattone]] comprendono sonnolenza, [[cefalea]], disturbi della motilità gastrointestinale, eruzioni cutanee, confusione mentale, rialzi termici, [[atassia]], [[ginecomastia]], disturbi dell’erezione, lievi effetti androgeni compreso irsutismo, irregolarità del ciclo mestruale. Tali effetti collaterali sono, in genere, reversibili con la sospensione del trattamento, in rari casi la [[ginecomastia]] può persistere. Gli effetti collaterali segnalati con l’uso di [[furosemide]] comprendono varie forme di [[dermatite]], eritema multiforme, [[prurito]], parestesia, offuscamento della vista, [[ipotensione]] posturale, [[nausea]], [[vomito]], [[diarrea]] e, più raramente, [[anemia]], [[leucopenia]], [[anemia]] aplastica e porpora trombocitopenica: sono stati anche segnalati casi reversibili di sordità e tinnito.&lt;br /&gt;
&lt;br /&gt;
==4.9 SOVRADOSAGGIO==&lt;br /&gt;
In caso di sovradosaggio è consigliabile eseguire controlli ripetuti della crasi ematica, degli elettroliti e della glicemia, dell’equilibrio acidobase, della pressione arteriosa, della volemia, dell’E.C.G. e in casi di variazioni oltre i limiti della norma procedere in senso correttivo.&lt;br /&gt;
&lt;br /&gt;
L’[[iperkaliemia]] può essere trattata con somministrazione endovenosa di glucosio (20-50%) e [[insulina]] (da 0,25 a 0,5 u. per grammo di glucosio).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''DATA DI REVISIONE DEL TESTO:''' Novembre 2010&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
[[Category:Farmaci]]&lt;/div&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	</feed>